TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TGTX Price/Volume Stats
| Current price | $22.18 | 52-week high | $26.41 |
| Prev. close | $21.83 | 52-week low | $6.46 |
| Day low | $21.65 | Volume | 2,153,600 |
| Day high | $22.22 | Avg. volume | 3,698,298 |
| 50-day MA | $22.66 | Dividend yield | N/A |
| 200-day MA | $18.13 | Market Cap | 3.43B |
TGTX Stock Price Chart Interactive Chart >
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
TGTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...